The science of allergic asthma & FeNO testing
FeNO is the least invasive, simplest, and most cost-effective means of predicting a patient’s response to therapy.
An intuitive and maintenance-free device for practices and clinics
Numerous studies verify the importance of FeNO measurement in delivering diagnosis confirmation and a prognosis of response to treatment with inhaled corticosteroids (ICS) for asthma patients.
Regular FeNO measurement simplifies the monitoring of airway inflammation and improves patients' adherence to ICS treatment.
FeNO-based therapy management can therefore help patients to keep better track of their asthma and help to avoid exacerbation.
This allows patients to enjoy their next walk to the full. This allows patients to enjoy their next walk to the full. Increased FeNO values predict a worsening of the disease course even before a conspicuous pulmonary function test and therefore allow early therapeutic countermeasures.
What is Fenom?
The centerpiece of the Fenom System, the Fenom Pro™ Asthma Monitor, is a new FeNO testing device that brings clarity to allergic asthma management at the point of care.
A cycle for managing inflammation
One FeNO test can only tell you so much. Integrating ongoing FeNO testing alongside standard asthma care practices can help harmonize personalized treatment guidance, dose titration, and patient adherence.
This FeNO-based inflammation control cycle helps manage treatment for patients with allergic asthma. Monitoring FeNO over time can help physicians anticipate exacerbations, validate seasonal factors, and preemptively adjust treatment.
With the Fenom System™, it’s easy to integrate Fenom Test-Treat-Test into the clinical care process, with results available in just 28 seconds.